MELE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 803
NA - Nord America 617
AS - Asia 298
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 1.726
Nazione #
US - Stati Uniti d'America 607
IE - Irlanda 280
SE - Svezia 158
IT - Italia 125
DE - Germania 109
IN - India 75
UA - Ucraina 68
CN - Cina 54
SG - Singapore 53
HK - Hong Kong 48
VN - Vietnam 40
IR - Iran 24
FI - Finlandia 23
GB - Regno Unito 14
FR - Francia 11
CA - Canada 10
AU - Australia 3
BE - Belgio 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
NL - Olanda 2
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.726
Città #
Dublin 275
Jacksonville 129
Dearborn 54
Hong Kong 48
Dong Ket 40
Singapore 39
Wilmington 39
Lawrence 31
Princeton 31
Bremen 27
San Mateo 24
Chandler 23
Beijing 21
Helsinki 17
Piemonte 16
Dallas 12
Zanjan 12
Ashburn 11
Andover 10
Milan 10
Monmouth Junction 10
Munich 9
Novara 9
Toronto 9
Alessandria 7
Fairfield 7
Turin 7
Santa Clara 6
Ardabil 5
Espoo 5
Hefei 5
Ann Arbor 4
Bologna 4
Borgo Vercelli 4
Cagliari 4
Kunming 4
Leawood 4
Norwalk 4
Pescantina 4
Rome 4
Berlin 3
Brussels 3
Des Moines 3
Vercelli 3
Woodbridge 3
Augusta 2
Boardman 2
Cambridge 2
Corsico 2
Debrecen 2
Galliate 2
Guangzhou 2
Hobart 2
Nanjing 2
Portland 2
Prague 2
San Francisco 2
Seattle 2
Tel Aviv 2
Vittoria 2
Amsterdam 1
Bangalore 1
Baotou 1
Brno 1
Cairo 1
Cergy 1
Changchun 1
Dundee 1
Eastleigh 1
Grafing 1
Gunzenhausen 1
Hebei 1
Henderson 1
Jena 1
Jiaxing 1
Jinan 1
Kish 1
London 1
Los Angeles 1
Louisville 1
Madrid 1
Mersin 1
Montichiari 1
Nanchang 1
Newark 1
Noicattaro 1
Pasadena 1
Porcia 1
Quito 1
Redwood City 1
Rivalta 1
Rostov-on-Don 1
Saint Louis 1
Saint Paul 1
San Diego 1
San Filippo 1
Shenyang 1
Tallinn 1
Torino 1
Varese 1
Totale 1.069
Nome #
Multifold aspects of obesity and insulin resistance: comorbidities and crosstalk with thyroid gland 113
Evaluation of the short-term effects of dietary supplement “Flebotrofine” on markers of endothelial dysfunction in type 2 diabetes patients: a pilot study. 91
Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy 87
Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life 74
Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS) 72
Transsphenoidal surgery for pituitary adenomas: early results from a single center 69
Thyroid cancer phenotypes in relation to inflammation and autoimmunity 66
Ovotesticular Disorder of Sex Development: A Rare Case of Lateral Subtype 45X/46XY kariotype Diagnosed in Adulthood 62
Embolization for Insulinoma in Complicated Severe Obesity: Description of an Inoperable Case and Review of the Literature 60
Clinical picture and the treatment of TBI-induced hypopituitarism 59
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables 55
Non-surgical ablative therapies for inoperable benign insulinoma 52
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome 52
Vitamin D and neurological diseases: An endocrine view 51
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals 50
Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities 49
Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome 48
Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations 48
Dynamic tests in pituitary endocrinology: pitfalls in interpretation during aging 47
null 45
Immunomodulatory effects of vitamin d in thyroid diseases 45
Insights into non-classic and emerging causes of hypopituitarism 45
The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity 44
The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC) 42
Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? 39
Real-world evaluation of weekly subcutaneous treatment with semaglutide in a cohort of Italian diabetic patients 39
Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma 38
Fat-free mass is better related to serum uric acid than metabolic homeostasis in Prader-Willi syndrome 38
Neuroinflammation and hypothalamo-pituitary dysfunction: Focus of traumatic brain injury 38
The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity 36
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry 35
Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes 32
Obesity and bone loss at menopause: The role of sclerostin 27
Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism 18
Could low prolactin levels after radiotherapy predict the onset of hypopituitarism? 11
Correction to: Transsphenoidal surgery for pituitary adenomas: early results from a single center (Hormones, (2018), 17, 4, (551-556), 10.1007/s42000-018-0082-9) 8
The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor? 5
Totale 1.790
Categoria #
all - tutte 10.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020252 0 0 0 0 0 37 60 11 24 99 21 0
2020/2021237 18 3 19 2 38 20 26 1 27 9 29 45
2021/2022281 19 18 21 39 23 2 11 9 13 5 65 56
2022/2023536 35 20 35 2 29 40 18 23 281 3 31 19
2023/2024224 23 33 14 10 30 0 47 11 0 4 23 29
2024/2025107 2 12 29 32 15 17 0 0 0 0 0 0
Totale 1.790